Octavio Burgués

4PUBLICATIONS
20CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 13, 2023
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.

Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues

|Feb 25, 2023
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.

Sandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano

|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.

Anna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell

|Aug 11, 2017
The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

O Burgués, Mª Á López-García, B Pérez-Míes

Pageof 1